Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (1) Blankenstein, Thomas Prof. Dr. (1) Blüthgen, Nils (1) Höpken, Uta Elisabeth PD Dr. (1) Kammertöns, Thomas Dr. (1) Kieback, Elisa Dr. (1) Kobelt, Dennis Dr. (1) Rehm, Armin Dr. (1) Wollert-Wulf, Brigitte (1) (-) Janz, Martin Dr. (1) (-) Leisegang, Matthias Dr. (1) (-) Lusatis, Simone (1) (-) Mathas, Stephan Dr. (1) (-) Uckert, Wolfgang Prof. Dr. (5) 2003 (5) 2004 (4) 2005 (4) (-) 2006 (3) 2007 (5) 2008 (3) (-) 2009 (3) 2010 (9) 2011 (3) 2012 (4) 2013 (5) 2014 (7) 2015 (7) 2016 (10) 2017 (4) 2018 (3) 2020 (2) 2021 (4) 2022 (1) Biology of Malignant Lymphomas (9) Developmental Biology / Signal Transduction (1) Genetics and Genomics of Cardiovascular Diseases (1) Mathematical Modelling of Cellular Processes (1) Microenvironmental Regulation in Autoimmunity and Cancer (1) (-) Molecular Cell Biology and Gene Therapy (6) Molecular Immunology and Gene Therapy (1) Proteome Dynamics (8) Signal Transduction in Development and Cancer (1) Structural Biology of Membrane-Associated Processes (1) Translational Oncology of Solid Tumors (1) 6 Results: Active Filter: Janz, Martin Dr.Leisegang, Matthias Dr.Lusatis, SimoneMathas, Stephan Dr.Uckert, Wolfgang Prof. Dr.Molecular Cell Biology and Gene Therapy20062009 Sort: Result score Newest to oldest Oldest to newest September 03, 2009 / Blood Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity S. Wilde D. Sommermeyer B. Frankenberger M. Schiemann S. Milosevic S. Spranger H. Pohla W. Uckert D.H. Busch D.J. Schendel August 01, 2009 / J Clin Invest The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells C. Rueder U.E. Höpken J. Wolf H.W. Mittruecker B. Engels B. Erdmann S. Wollenzin W. Uckert B. Dörken A. Rehm May 01, 2009 / Cancer Immunol Immunother TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008 W. Uckert T.N. Schumacher November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert March 01, 2006 / Cell Mol Life Sci The translocation motif of hepatitis B virus improves protein vaccination E. Bleifuss T. Kammertoens A. Hutloff D. Quarcoo M. Dorner P. Straub W. Uckert E. Hildt February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
September 03, 2009 / Blood Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity S. Wilde D. Sommermeyer B. Frankenberger M. Schiemann S. Milosevic S. Spranger H. Pohla W. Uckert D.H. Busch D.J. Schendel
August 01, 2009 / J Clin Invest The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells C. Rueder U.E. Höpken J. Wolf H.W. Mittruecker B. Engels B. Erdmann S. Wollenzin W. Uckert B. Dörken A. Rehm
May 01, 2009 / Cancer Immunol Immunother TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008 W. Uckert T.N. Schumacher
November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
March 01, 2006 / Cell Mol Life Sci The translocation motif of hepatitis B virus improves protein vaccination E. Bleifuss T. Kammertoens A. Hutloff D. Quarcoo M. Dorner P. Straub W. Uckert E. Hildt
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
